Home/Pipeline/Fostamatinib

Fostamatinib

Warm Autoimmune Hemolytic Anemia (wAIHA)

Phase 3Active

Key Facts

Indication
Warm Autoimmune Hemolytic Anemia (wAIHA)
Phase
Phase 3
Status
Active
Company

About Mochida Pharmaceutical

Founded in 1895, Mochida Pharmaceutical is a long-standing Japanese pharmaceutical company focused on the research, development, and commercialization of innovative medicines and healthcare products. The company operates across three core segments: Prescription Pharmaceuticals, Consumer Healthcare (OTC), and Diagnostics. Its strategy combines the lifecycle management of its established revenue-generating products with targeted R&D in areas such as oncology, immunology, and rare diseases to drive future growth.

View full company profile

Other Warm Autoimmune Hemolytic Anemia (wAIHA) Drugs

DrugCompanyPhase
ANX005AnnexonPhase 2